PulmoSIM Therapeutics has joined with scientists at National Jewish Health hospital and Brown University to advance PT001, its investigational…
Articles by Patricia Inácio, PhD
U.S. veterans infected with the human immunodeficiency virus (HIV) — the virus that causes AIDS — are at higher risk…
Joining support groups — meeting people with common experiences and concerns who can provide emotional reassurance — for pulmonary…
Despite a high-risk of serious complications, 10 women with moderate to severe pulmonary arterial hypertension (PAH) had a successful…
Treatment with a single medication (monotherapy) may be sufficient to help manage people with “atypical” pulmonary arterial hypertension (PAH),…
Ahead of this year’s Rare Disease Week on Capitol Hill, held virtually July 14–22, the EveryLife Foundation will…
Medical care for patients with pulmonary hypertension (PH) was affected during the first wave of the COVID-19 pandemic,…
More than half of the people with rare diseases and their caregivers, asked in a survey, were undecided or less…
Pulmonary hypertension (PH) increases the likelihood of a prolonged hospitalization following an acute ischemic stroke, or a stroke due…
The EveryLife Foundation for Rare Diseases is accepting applications for a scholarship program that aims to help adults with a…
Matt J. Granato is the newly named president and CEO of the Pulmonary Hypertension Association (PHA), the nonprofit group…
Treatment with bosentan may lower the risk of developing pulmonary hypertension (PH) and help stabilize lung function in…